After eight years in development, FDA’s Sentinel system is poised to play a more visible role in assessing medical product efficacy, as well as safety. There are plans to expand it to gather information on the performance of medical products in real world settings, which may assist researchers and clinicians in answering broader questions about treatment use.
Read More: appliedclinicaltrialsonline.com
